{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:53:49Z","timestamp":1791251629882,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00894-026-06893-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:58:42Z","timestamp":1789549122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure-guided identification of histone deacetylase 11 inhibitors for targeted chemotherapy through long-timescale molecular dynamics simulation"],"prefix":"10.1007","volume":"32","author":[{"given":"Koustav","family":"Maiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deotima","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekar","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshine","family":"Gnanasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevedha","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Velusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"6893_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6:a018713. https:\/\/doi.org\/10.1101\/cshperspect.a018713","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6893_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.272.5260.408","volume":"272","author":"J Taunton","year":"1996","unstructured":"Taunton J, Hassig CA, Schreiber SL (1996) A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272:408\u2013411. https:\/\/doi.org\/10.1126\/science.272.5260.408","journal-title":"Science"},{"key":"6893_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrg2485","volume":"10","author":"M Haberland","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10:32\u201342. https:\/\/doi.org\/10.1038\/nrg2485","journal-title":"Nat Rev Genet"},{"key":"6893_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/146493","volume":"2011","author":"Y-L Yao","year":"2011","unstructured":"Yao Y-L, Yang W-M (2011) Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates. BioMed Res Int 2011:146493. https:\/\/doi.org\/10.1155\/2011\/146493","journal-title":"BioMed Res Int"},{"key":"6893_CR5","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J et al (2021) Recent developments of HDAC inhibitors: emerging indications and novel molecules. Br J Clin Pharmacol 87:4577\u20134597. https:\/\/doi.org\/10.1111\/bcp.14889","journal-title":"Br J Clin Pharmacol"},{"key":"6893_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/radiation2010011","volume":"2","author":"J Antrobus","year":"2022","unstructured":"Antrobus J, Parsons JL (2022) Histone deacetylases and their potential as targets to enhance tumour radiosensitisation. Radiation (Tokyo) 2:149\u2013167. https:\/\/doi.org\/10.3390\/radiation2010011","journal-title":"Radiation (Tokyo)"},{"key":"6893_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.4093\/dmj.2023.0174","volume":"48","author":"H Kang","year":"2024","unstructured":"Kang H, Park Y-K, Lee J-Y, Bae M (2024) Roles of histone deacetylase 4 in the inflammatory and metabolic processes. Diabetes Metab J 48:340\u2013353. https:\/\/doi.org\/10.4093\/dmj.2023.0174","journal-title":"Diabetes Metab J"},{"key":"6893_CR8","doi-asserted-by":"publisher","first-page":"15064","DOI":"10.1073\/pnas.0404603101","volume":"101","author":"A Vannini","year":"2004","unstructured":"Vannini A, Volpari C, Filocamo G et al (2004) Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci USA 101:15064\u201315069. https:\/\/doi.org\/10.1073\/pnas.0404603101","journal-title":"Proc Natl Acad Sci USA"},{"key":"6893_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/43710","volume":"401","author":"MS Finnin","year":"1999","unstructured":"Finnin MS, Donigian JR, Cohen A et al (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401:188\u2013193. https:\/\/doi.org\/10.1038\/43710","journal-title":"Nature"},{"key":"6893_CR10","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1074\/jbc.M109.033399","volume":"285","author":"SL Gantt","year":"2010","unstructured":"Gantt SL, Joseph CG, Fierke CA (2010) Activation and inhibition of histone deacetylase 8 by monovalent cations. J Biol Chem 285:6036\u20136043. https:\/\/doi.org\/10.1074\/jbc.M109.033399","journal-title":"J Biol Chem"},{"key":"6893_CR11","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1021\/ja103932d","volume":"132","author":"R Wu","year":"2010","unstructured":"Wu R, Wang S, Zhou N et al (2010) A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions. J Am Chem Soc 132:9471\u20139479. https:\/\/doi.org\/10.1021\/ja103932d","journal-title":"J Am Chem Soc"},{"key":"6893_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","volume":"277","author":"O Witt","year":"2009","unstructured":"Witt O, Deubzer HE, Milde T, Oehme I (2009) HDAC family: what are the cancer relevant targets. Cancer Lett 277:8\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2008.08.016","journal-title":"Cancer Lett"},{"key":"6893_CR13","first-page":"151","volume":"2","author":"KB Glaser","year":"2003","unstructured":"Glaser KB, Staver MJ, Waring JF et al (2003) Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther 2:151\u2013163","journal-title":"Mol Cancer Ther"},{"key":"6893_CR14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1684\/bdc.2010.1121","volume":"97","author":"N P\u00e9cuchet","year":"2010","unstructured":"P\u00e9cuchet N, Cluzeau T, Thibault C et al (2010) Inhibiteurs des histone-d\u00e9sac\u00e9tylases : la r\u00e9gulation \u00e9pig\u00e9n\u00e9tique sort de l\u2019ombre. Bull Cancer 97:917\u2013935. https:\/\/doi.org\/10.1684\/bdc.2010.1121","journal-title":"Bull Cancer"},{"key":"6893_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045422","volume":"7","author":"D Banik","year":"2012","unstructured":"Banik D, Khan ANH, Walseng E et al (2012) Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity. PLoS ONE 7:e45422. https:\/\/doi.org\/10.1371\/journal.pone.0045422","journal-title":"PLoS ONE"},{"key":"6893_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","volume":"113","author":"HJ Kee","year":"2006","unstructured":"Kee HJ, Sohn IS, Nam KI et al (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circ 113:51\u201359. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.559724","journal-title":"Circ"},{"key":"6893_CR17","doi-asserted-by":"publisher","unstructured":"Pang M, Kothapally J, Mao H et al (2009) Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 297:F996. https:\/\/doi.org\/10.1152\/ajprenal.00282.2009","DOI":"10.1152\/ajprenal.00282.2009"},{"key":"6893_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1165\/rcmb.2011-0040OC","volume":"46","author":"ER Davies","year":"2012","unstructured":"Davies ER, Haitchi HM, Thatcher TH et al (2012) Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am J Respir Cell Mol Biol 46:687\u2013694. https:\/\/doi.org\/10.1165\/rcmb.2011-0040OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"6893_CR19","doi-asserted-by":"publisher","first-page":"F133","DOI":"10.1152\/ajprenal.00400.2009","volume":"298","author":"T Marumo","year":"2010","unstructured":"Marumo T, Hishikawa K, Yoshikawa M et al (2010) Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 298:F133\u2013F141. https:\/\/doi.org\/10.1152\/ajprenal.00400.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"6893_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2010-05-284711","volume":"117","author":"T Roger","year":"2011","unstructured":"Roger T, Lugrin J, Le Roy D et al (2011) Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117:1205\u20131217","journal-title":"Blood"},{"key":"6893_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1021\/jm200773h","volume":"55","author":"JH Kalin","year":"2012","unstructured":"Kalin JH, Butler KV, Akimova T et al (2012) Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells. J Med Chem 55:639\u2013651. https:\/\/doi.org\/10.1021\/jm200773h","journal-title":"J Med Chem"},{"key":"6893_CR22","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1248\/bpb.31.1723","volume":"31","author":"F Kinugasa","year":"2008","unstructured":"Kinugasa F, Yamada T, Noto T et al (2008) Effect of a new immunosuppressant histon deacetylase (HDAC) inhibitor FR276457 in a rat cardiac transplant model. Biol Pharm Bull 31:1723\u20131726. https:\/\/doi.org\/10.1248\/bpb.31.1723","journal-title":"Biol Pharm Bull"},{"key":"6893_CR23","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1073\/pnas.052702999","volume":"99","author":"F Leoni","year":"2002","unstructured":"Leoni F, Zaliani A, Bertolini G et al (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci USA 99:2995\u20133000. https:\/\/doi.org\/10.1073\/pnas.052702999","journal-title":"Proc Natl Acad Sci USA"},{"key":"6893_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.2011.154211","volume":"71","author":"AM Grabiec","year":"2012","unstructured":"Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA (2012) Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann Rheum Dis 71:424\u2013431. https:\/\/doi.org\/10.1136\/ard.2011.154211","journal-title":"Ann Rheum Dis"},{"key":"6893_CR25","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2337\/db11-0440","volume":"60","author":"O Lenoir","year":"2011","unstructured":"Lenoir O, Flosseau K, Ma FX et al (2011) Specific control of pancreatic endocrine \u03b2- and \u03b4-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9. Diabetes 60:2861\u20132871. https:\/\/doi.org\/10.2337\/db11-0440","journal-title":"Diabetes"},{"key":"6893_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2119\/molmed.2010.00152","volume":"17","author":"EC Lewis","year":"2011","unstructured":"Lewis EC, Blaabjerg L, St\u00f8rling J et al (2011) The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet \u03b2 cells in vivo and in vitro. Mol Med 17:369\u2013377. https:\/\/doi.org\/10.2119\/molmed.2010.00152","journal-title":"Mol Med"},{"key":"6893_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1182\/blood.2019895326","volume":"135","author":"L Yue","year":"2020","unstructured":"Yue L, Sharma V, Horvat NP et al (2020) HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms. Blood 135:191\u2013207. https:\/\/doi.org\/10.1182\/blood.2019895326","journal-title":"Blood"},{"key":"6893_CR28","doi-asserted-by":"publisher","first-page":"25748","DOI":"10.1074\/jbc.M111871200","volume":"277","author":"L Gao","year":"2002","unstructured":"Gao L, Cueto MA, Asselbergs F, Atadja P (2002) Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 277:25748\u201325755. https:\/\/doi.org\/10.1074\/jbc.M111871200","journal-title":"J Biol Chem"},{"key":"6893_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12864-019-5973-x","volume":"20","author":"TA Boltz","year":"2019","unstructured":"Boltz TA, Khuri S, Wuchty S (2019) Promoter conservation in HDACs points to functional implications. BMC Genomics 20:613","journal-title":"BMC Genomics"},{"key":"6893_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00125-010-1892-8","volume":"53","author":"M Lundh","year":"2010","unstructured":"Lundh M, Christensen DP, Rasmussen DN et al (2010) Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines. Diabetologia 53:2569\u20132578. https:\/\/doi.org\/10.1007\/s00125-010-1892-8","journal-title":"Diabetologia"},{"key":"6893_CR31","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.4049\/jimmunol.1302778","volume":"193","author":"F Cheng","year":"2014","unstructured":"Cheng F, Lienlaf M, Wang H-W et al (2014) A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3\/IL-10 pathway in APCs. J Immunol 193:2850\u20132862. https:\/\/doi.org\/10.4049\/jimmunol.1302778","journal-title":"J Immunol"},{"key":"6893_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbagrm.2017.12.002","volume":"1861","author":"C Yanginlar","year":"2018","unstructured":"Yanginlar C, Logie C (2018) HDAC11 is a regulator of diverse immune functions. Biochim Biophys Acta - Gene Regul Mech 1861:54\u201359. https:\/\/doi.org\/10.1016\/j.bbagrm.2017.12.002","journal-title":"Biochim Biophys Acta - Gene Regul Mech"},{"key":"6893_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ni.1673","volume":"10","author":"A Villagra","year":"2009","unstructured":"Villagra A, Cheng F, Wang H-W et al (2009) The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 10:92\u2013100. https:\/\/doi.org\/10.1038\/ni.1673","journal-title":"Nat Immunol"},{"key":"6893_CR34","doi-asserted-by":"publisher","first-page":"50577","DOI":"10.1021\/acsomega.5c08195","volume":"10","author":"S Hilscher","year":"2025","unstructured":"Hilscher S, Meleshin M, Baselious F et al (2025) Substrate-guided development of HDAC11-selective inhibitors featuring \u03b1-amino amide zinc-binding groups. ACS Omega 10:50577\u201350587. https:\/\/doi.org\/10.1021\/acsomega.5c08195","journal-title":"ACS Omega"},{"key":"6893_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open Babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"6893_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1140\/epjc\/s10052-024-12645-5","volume":"84","author":"WH Dai","year":"2024","unstructured":"Dai WH, Ma H, Zeng Z et al (2024) Virtual segmentation of a small contact HPGe detector: inference of hit positions of single-site events via pulse shape analysis. Eur Phys J C 84:294. https:\/\/doi.org\/10.1140\/epjc\/s10052-024-12645-5","journal-title":"Eur Phys J C"},{"key":"6893_CR37","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1021\/jm7009217","volume":"50","author":"Y Itoh","year":"2007","unstructured":"Itoh Y, Suzuki T, Kouketsu A et al (2007) Design, synthesis, structure\u2212selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. J Med Chem 50:5425\u20135438. https:\/\/doi.org\/10.1021\/jm7009217","journal-title":"J Med Chem"},{"key":"6893_CR38","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1093\/nar\/gkaf1060","volume":"54","author":"EW Sayers","year":"2026","unstructured":"Sayers EW, Bolton EE, Fine AM et al (2026) Database resources of the National Center for Biotechnology Information in 2026. Nucleic Acids Research 54:D20\u2013D27. https:\/\/doi.org\/10.1093\/nar\/gkaf1060","journal-title":"Nucleic Acids Research"},{"key":"6893_CR39","first-page":"4191","volume-title":"Handbook of spices in India: 75 years of research and development","author":"R Meenakumari","year":"2024","unstructured":"Meenakumari R, Suba V, Shakthi Paargavi A, Karthik K (2024) Spices in Siddha traditional medicine. In: Ravindran PN, Sivaraman K, Devasahayam S, Babu KN (eds) Handbook of spices in India: 75 years of research and development. Springer Nature Singapore, Singapore, pp 4191\u20134216"},{"key":"6893_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102793","volume":"129","author":"OA O\u2019Connor","year":"2024","unstructured":"O\u2019Connor OA, Ma H, Chan JYS et al (2024) Peripheral T-cell lymphoma: from biology to practice to the future. Cancer Treatment Rev 129:102793. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102793","journal-title":"Cancer Treatment Rev"},{"key":"6893_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116466","volume":"227","author":"G Fan","year":"2024","unstructured":"Fan G, Zhang Y, Li Q et al (2024) BCL6 confers resistance to HDAC inhibitors in DLBCL. Biochem Pharmacol 227:116466. https:\/\/doi.org\/10.1016\/j.bcp.2024.116466","journal-title":"Biochem Pharmacol"},{"key":"6893_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s12272-023-01467-w","volume":"46","author":"SK Gupta","year":"2023","unstructured":"Gupta SK, Ali KH, Lee S, Seo YH (2023) Exploring new histone deacetylase 6 inhibitors and their effects on reversing the \u03b1-tubulin deacetylation and cell morphology changes caused by methamphetamine. Arch Pharm Res 46:795\u2013807. https:\/\/doi.org\/10.1007\/s12272-023-01467-w","journal-title":"Arch Pharm Res"},{"key":"6893_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12864-024-10029-3","volume":"25","author":"R Shao","year":"2024","unstructured":"Shao R, Suzuki T, Suyama M, Tsukada Y (2024) The impact of selective HDAC inhibitors on the transcriptome of early mouse embryos. BMC Genom 25:143. https:\/\/doi.org\/10.1186\/s12864-024-10029-3","journal-title":"BMC Genom"},{"key":"6893_CR44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s11912-024-01570-1","volume":"26","author":"S Lessans","year":"2024","unstructured":"Lessans S, O\u2019Connell KA, Choe J (2024) Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances. Curr Oncol Rep 26:1120\u20131133. https:\/\/doi.org\/10.1007\/s11912-024-01570-1","journal-title":"Curr Oncol Rep"},{"key":"6893_CR45","doi-asserted-by":"publisher","first-page":"o4272","DOI":"10.1107\/S1600536807048106","volume":"63","author":"W Frey","year":"2007","unstructured":"Frey W, W\u00f6lfle M, Hashmi ASK (2007) Meso -2-Methyl-5-[2-(4-methylfuran-2-yl)-1,2-bis(prop-2-ynyloxy)ethyl]furan. Acta Crystallogr E Struct Rep Online 63:o4272\u2013o4272. https:\/\/doi.org\/10.1107\/S1600536807048106","journal-title":"Acta Crystallogr E Struct Rep Online"},{"key":"6893_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41698-024-00589-8","volume":"8","author":"PJ Lawrence","year":"2024","unstructured":"Lawrence PJ, Burns B, Ning X (2024) Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization. NPJ Precis Onc 8:106. https:\/\/doi.org\/10.1038\/s41698-024-00589-8","journal-title":"NPJ Precis Onc"},{"key":"6893_CR47","first-page":"873","volume":"12","author":"P-Y Huang","year":"2022","unstructured":"Huang P-Y, Shih I-A, Liao Y-C et al (2022) A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway. Am J Cancer Res 12:873\u2013892","journal-title":"Am J Cancer Res"},{"key":"6893_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-3-030-27378-1_63","volume":"1185","author":"M Samardzija","year":"2019","unstructured":"Samardzija M, Masarini K, Ueffing M, Trifunovi\u0107 D (2019) HDAC Inhibition Prevents Primary Cone Degeneration Even After the Onset of Degeneration. Adv Exp Med Biol 1185:383\u2013387. https:\/\/doi.org\/10.1007\/978-3-030-27378-1_63","journal-title":"Adv Exp Med Biol"},{"key":"6893_CR49","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.121.17149","volume":"78","author":"JK Jung","year":"2021","unstructured":"Jung JK, Yoon G-E, Jang G et al (2021) Inhibition of HDACs (histone deacetylases) ameliorates high-fat diet\u2013induced hypertension through restoration of the MsrA (Methionine sulfoxide reductase A)\/hydrogen sulfide axis. Hypertension 78:1103\u20131115. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.17149","journal-title":"Hypertension"},{"key":"6893_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jcis.2024.06.091","volume":"673","author":"FD Victorelli","year":"2024","unstructured":"Victorelli FD, Lutz-Bueno V, Santos KP et al (2024) Cubosomes functionalized with antibodies as a potential strategy for the treatment of HER2-positive breast cancer. J Colloid Interface Sci 673:291\u2013300. https:\/\/doi.org\/10.1016\/j.jcis.2024.06.091","journal-title":"J Colloid Interface Sci"},{"key":"6893_CR51","doi-asserted-by":"publisher","unstructured":"Monincov\u00e1 L, Bud\u011b\u0161\u00ednsk\u00fd M, Slaninov\u00e1 J, et al (2010) Novel antimicrobial peptides from the venom of the eusocial bee Halictus sexcinctus (Hymenoptera: Halictidae) and their analogs. Amino Acids39:763\u2013775. https:\/\/doi.org\/10.1007\/s00726-010-0519-1","DOI":"10.1007\/s00726-010-0519-1"},{"key":"6893_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13321-024-00856-7","volume":"16","author":"RM Mogire","year":"2024","unstructured":"Mogire RM, Miruka SA, Juma DW et al (2024) Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparum. J Cheminform 16:63. https:\/\/doi.org\/10.1186\/s13321-024-00856-7","journal-title":"J Cheminform"},{"key":"6893_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114922","volume":"380","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang X, Wang J et al (2024) ClassIIb histone deacetylase participates in perioperative neurocognitive disorders in elderly mice via HSP90\/GR signaling pathway. Exp Neurol 380:114922. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114922","journal-title":"Exp Neurol"},{"key":"6893_CR54","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1007\/s13577-024-01122-6","volume":"37","author":"J Osaki","year":"2024","unstructured":"Osaki J, Noguchi R, Ono T et al (2024) Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma. Human Cell 37:1734\u20131741. https:\/\/doi.org\/10.1007\/s13577-024-01122-6","journal-title":"Human Cell"},{"key":"6893_CR55","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nchembio.2140","volume":"12","author":"Y Miyake","year":"2016","unstructured":"Miyake Y, Keusch JJ, Wang L et al (2016) Structural insights into HDAC6 tubulin deacetylation and its selective inhibition. Nat Chem Biol 12:748\u2013754. https:\/\/doi.org\/10.1038\/nchembio.2140","journal-title":"Nat Chem Biol"},{"key":"6893_CR56","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"6893_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/jop.2021.0069","volume":"38","author":"TK Karami","year":"2022","unstructured":"Karami TK, Hailu S, Feng S et al (2022) Eyes on Lipinski\u2019s Rule of Five: a new \u201crule of thumb\u201d for physicochemical design space of ophthalmic drugs. J Ocul Pharmacol Ther 38:43\u201355. https:\/\/doi.org\/10.1089\/jop.2021.0069","journal-title":"J Ocul Pharmacol Ther"},{"key":"6893_CR58","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 52:W513\u2013W520. https:\/\/doi.org\/10.1093\/nar\/gkae303","journal-title":"Nucleic Acids Res"},{"key":"6893_CR59","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"6893_CR60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10989-020-10149-w","volume":"27","author":"PC Sekar","year":"2021","unstructured":"Sekar PC, Rajasekaran R (2021) Could dermaseptin analogue be a competitive inhibitor for ace2 towards binding with viral spike protein causing COVID19?: Computational investigation. Int J Pept Res Ther 27:1043\u20131056. https:\/\/doi.org\/10.1007\/s10989-020-10149-w","journal-title":"Int J Pept Res Ther"},{"key":"6893_CR61","doi-asserted-by":"publisher","first-page":"W318","DOI":"10.1093\/nar\/gkae270","volume":"52","author":"AM Waterhouse","year":"2024","unstructured":"Waterhouse AM, Studer G, Robin X et al (2024) The structure assessment web server: for proteins, complexes and more. Nucleic Acids Research 52:W318\u2013W323. https:\/\/doi.org\/10.1093\/nar\/gkae270","journal-title":"Nucleic Acids Research"},{"key":"6893_CR62","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/elps.1150181505","volume":"18","author":"N Guex","year":"1997","unstructured":"Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 18:2714\u20132723. https:\/\/doi.org\/10.1002\/elps.1150181505","journal-title":"Electrophoresis"},{"key":"6893_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume-title":"Chemical Biology","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. In: Hempel JE, Williams CH, Hong CC (eds) Chemical Biology. Springer, New York, New York, NY, pp 243\u2013250"},{"key":"6893_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00894-022-05117-8","volume":"28","author":"PC Sekar","year":"2022","unstructured":"Sekar PC, Srinivasan E, Chandrasekhar G et al (2022) Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19. J Mol Model 28:128. https:\/\/doi.org\/10.1007\/s00894-022-05117-8","journal-title":"J Mol Model"},{"key":"6893_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, De Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des 24:417\u2013422. https:\/\/doi.org\/10.1007\/s10822-010-9352-6","journal-title":"J Comput Aided Mol Des"},{"key":"6893_CR66","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ et al (2015) PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res 43:W443\u2013W447. https:\/\/doi.org\/10.1093\/nar\/gkv315","journal-title":"Nucleic Acids Res"},{"key":"6893_CR67","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10989-021-10265-1","volume":"27","author":"P Chandra Sekar","year":"2021","unstructured":"Chandra Sekar P, Chandrasekhar G, Rajasekaran R (2021) Hydrophobic residues confer the helicity and membrane permeability of ocellatin-1 antimicrobial peptide scaffold towards therapeutics. Int J Pept Res Ther 27:2459\u20132470. https:\/\/doi.org\/10.1007\/s10989-021-10265-1","journal-title":"Int J Pept Res Ther"},{"key":"6893_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"6893_CR69","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems. J Chem Phys 98:10089\u201310092. https:\/\/doi.org\/10.1063\/1.464397","journal-title":"J Chem Phys"},{"key":"6893_CR70","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577\u20138593. https:\/\/doi.org\/10.1063\/1.470117","journal-title":"J Chem Phys"},{"key":"6893_CR71","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12","journal-title":"J Comput Chem"},{"key":"6893_CR72","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/acschembio.9b00292","volume":"14","author":"SI Son","year":"2019","unstructured":"Son SI, Cao J, Zhu CL, Miller SP, Lin H (2019) Activity-guided design of HDAC11-specific inhibitors. ACS Chem Biol 14:1393\u20131397. https:\/\/doi.org\/10.1021\/acschembio.9b00292","journal-title":"ACS Chem Biol"},{"key":"6893_CR73","doi-asserted-by":"publisher","unstructured":"MacKerell AD Jr, Bashford D, Bellott M, Dunbrack RL Jr, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE III, Roux B, Schlenkrich S, Smith JC, Stote R, Straub J, Watanabe M, Wi\u00f3rkiewicz- Kuczera J, Yin D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586\u20133616. https:\/\/doi.org\/10.1021\/jp973084f","DOI":"10.1021\/jp973084f"},{"key":"6893_CR74","doi-asserted-by":"publisher","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","DOI":"10.1002\/jcc.21816"},{"key":"6893_CR75","doi-asserted-by":"publisher","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","DOI":"10.1063\/1.445869"},{"key":"6893_CR76","doi-asserted-by":"publisher","unstructured":"Baselious F, Hilscher S, Robaa D, Barinka C, Schutkowski M, Sippl W (2024) Comparative structure-based virtual screening utilizing optimized AlphaFold model identifies selective HDAC11 inhibitor. Int J Mol Sci 25(2):1358. https:\/\/doi.org\/10.3390\/ijms25021358","DOI":"10.3390\/ijms25021358"},{"key":"6893_CR77","doi-asserted-by":"publisher","unstructured":"Jia G, Liu J, Hou X et al (2024) Biological function and small molecule inhibitors of histone deacetylase 11. Eur J Med Chem 276:116634. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116634","DOI":"10.1016\/j.ejmech.2024.116634"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06893-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00894-026-06893-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-026-06893-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:19Z","timestamp":1791250099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00894-026-06893-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["6893"],"URL":"https:\/\/doi.org\/10.1007\/s00894-026-06893-3","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"value":"1610-2940","type":"print"},{"value":"0948-5023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"375"}}